TD Cowen Downgrades Cardiff Oncology to Hold

Benzinga Newsdesk www.benzinga.com Negative 86.1%

Neg 86.1% Neu 0% Pos 0%

TD Cowen analyst Marc Frahm downgrades Cardiff Oncology (NASDAQ:CRDF) from Buy to Hold.

Comments

No comments yet. Be the first!